Frontiers | Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy | Pharmacology
Summary of oxaliplatin-associated resistance mechanisms. Arrows and... | Download Scientific Diagram
Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis - Hsu - 2018 - Journal of Cellular Physiology - Wiley Online Library
Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents | PNAS
Oxaliplatin-related thrombocytopenia - Annals of Oncology
Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione - Metallomics (RSC Publishing)
Dose and Sequence Dependent Synergism from the Combination of Oxaliplatin with Emetine and Patulin Against Colorectal Cancer | Bentham Science
Nutrients | Free Full-Text | Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G0/G1 to Apoptosis in HCT116 Human Colorectal Carcinoma Cells | HTML
Chemotherapy-induced peripheral neuropathy - ANS Biotech
Mechanism of action of vincristine, paclitaxel, oxaliplatin and... | Download Scientific Diagram
Oxaliplatin - Wikipedia
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan - ScienceDirect
Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin - Journal of Biological Chemistry
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2: Molecular Therapy - Oncolytics
Identification of drug transporters contributing to oxaliplatin‐induced peripheral neuropathy - Fujita - 2019 - Journal of Neurochemistry - Wiley Online Library
Platinum-containing cancer drugs have different mechanisms
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink
Oxaliplatin | Nature Reviews Drug Discovery
The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease
Oxaliplatin (Eloxatin) - Oncology Nurse Advisor
Oxaliplatin-Induced Evans Syndrome: A Possible Dual Mechanism - Clinical Colorectal Cancer
Oxaliplatin (NSC 266046) | ≥99%(HPLC) | Selleck | DNA/RNA Synthesis inhibitor
Oxaliplatin Uses JNK to Restore TRAIL Sensitivity in Cancer Cells Through Bcl-xL Inactivation - Gastroenterology
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink
Oxaliplatin - an overview | ScienceDirect Topics
![PDF] Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/75b591a44311c967921d4c1e1635fdd079853677/2-Figure1-1.png "PDF] Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | Semantic Scholar")
PDF] Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | Semantic Scholar
Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer - ScienceDirect
